Harold Farber - Publications

Affiliations: 
Texas Children's Hospital, Houston, United States 

6/249 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Preston IR, Roberts KE, Miller DP, Sen GP, Selej M, Benton WW, Hill NS, Farber HW. Effect of Warfarin Treatment on Survival of Patients with Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL). Circulation. PMID 26510696 DOI: 10.1161/CIRCULATIONAHA.115.018435  0.301
2013 Frost AE, Farber HW, Barst RJ, Miller DP, Elliott CG, McGoon MD. Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18 mm Hg: insights from the REVEAL Registry. Chest. 143: 185-95. PMID 22661451 DOI: 10.1378/chest.11-1387  0.307
2012 Skondra D, Chang GC, Farber HW, Eliott D. Ophthalmologic diagnosis of exacerbation of idiopathic pulmonary arterial hypertension. Archives of Ophthalmology (Chicago, Ill. : 1960). 130: 1619-21. PMID 23229713 DOI: 10.1001/archophthalmol.2012.1802  0.3
2011 Mallory GB, Hanna BD, Ivy DD, Shardonofsky F, Farber HJ. Management and Controversies in Pediatric Pulmonary Hypertension. Pediatric Allergy, Immunology, and Pulmonology. 22: 139-150. PMID 21766047 DOI: 10.1089/Pai.2009.2204.Rt  0.411
2010 Farber HW, Walkey AJ, Alikhan MM. The role of aldosterone in pulmonary venous hypertension. Chest. 137: 502; author reply 50. PMID 20133311 DOI: 10.1378/chest.09-1864  0.307
2005 McLoughlin P, Hyvelin JM, Howell K, Tektonidou M, Farber HW, Loscalzo J. Pulmonary hypertension [5] (multiple letters) New England Journal of Medicine. 352: 418-419. PMID 15675104 DOI: 10.1056/NEJM200501273520421  0.305
Low-probability matches (unlikely to be authored by this person)
2012 Badesch DB, Feldman J, Keogh A, Mathier MA, Oudiz RJ, Shapiro S, Farber HW, McGoon M, Frost A, Allard M, Despain D, Dufton C, Rubin LJ. ARIES-3: ambrisentan therapy in a diverse population of patients with pulmonary hypertension. Cardiovascular Therapeutics. 30: 93-9. PMID 21884013 DOI: 10.1111/j.1755-5922.2011.00279.x  0.298
2008 Farber HW. The status of pulmonary arterial hypertension in 2008. Circulation. 117: 2966-8. PMID 18541751 DOI: 10.1161/CIRCULATIONAHA.108.782979  0.293
2004 Farber HW, Loscalzo J. Pulmonary arterial hypertension. The New England Journal of Medicine. 351: 1655-65. PMID 15483284 DOI: 10.1056/Nejmra035488  0.292
2011 Walkey AJ, Fein D, Horbowicz KJ, Farber HW. Differential response to intravenous prostacyclin analog therapy in patients with pulmonary arterial hypertension. Pulmonary Pharmacology & Therapeutics. 24: 421-5. PMID 21251994 DOI: 10.1016/j.pupt.2011.01.002  0.292
2005 Preston IR, Klinger JR, Houtches J, Nelson D, Farber HW, Hill NS. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension. Respiratory Medicine. 99: 1501-10. PMID 15890512 DOI: 10.1016/j.rmed.2005.03.026  0.29
2010 Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, Barst RJ, Benza RL, Liou TG, Turner M, Giles S, Feldkircher K, Miller DP, McGoon MD. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 137: 376-87. PMID 19837821 DOI: 10.1378/Chest.09-1140  0.29
2006 Steiner MK, Preston IR, Klinger JR, Criner GJ, Waxman AB, Farber HW, Hill NS. Conversion to bosentan from prostacyclin infusion therapy in pulmonary arterial hypertension: a pilot study. Chest. 130: 1471-80. PMID 17099026 DOI: 10.1378/chest.130.5.1471  0.287
2013 Esch JJ, Shah PB, Cockrill BA, Farber HW, Landzberg MJ, Mehra MR, Mullen MP, Opotowsky AR, Waxman AB, Lock JE, Marshall AC. Transcatheter Potts shunt creation in patients with severe pulmonary arterial hypertension: initial clinical experience. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 32: 381-7. PMID 23415728 DOI: 10.1016/j.healun.2013.01.1049  0.287
2005 Farber HW, Loscalzo J. Mechanism of disease: Pulmonary hypertension. Discovery Medicine. 5: 80-7. PMID 20704929  0.286
2006 Patterson KC, Weissmann A, Ahmadi T, Farber HW. Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension. Annals of Internal Medicine. 145: 152-3. PMID 16847299  0.285
2014 Gopal DM, Doldt B, Finch K, Simms RW, Farber HW, Gokce N. Relation of novel echocardiographic measures to invasive hemodynamic assessment in scleroderma-associated pulmonary arterial hypertension. Arthritis Care & Research. 66: 1386-94. PMID 24515598 DOI: 10.1002/acr.22307  0.283
2006 Fisher KA, Serlin DM, Wilson KC, Walter RE, Berman JS, Farber HW. Sarcoidosis-associated pulmonary hypertension: outcome with long-term epoprostenol treatment. Chest. 130: 1481-8. PMID 17099027 DOI: 10.1378/chest.130.5.1481  0.283
2015 Farber HW, Miller DP, Poms AD, Badesch DB, Frost AE, Muros-Le Rouzic E, Romero AJ, Benton WW, Elliott CG, McGoon MD, Benza RL. Five-year Outcomes of Patients Enrolled in the Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension (PAH) Disease Management (REVEAL). Chest. PMID 26066077 DOI: 10.1378/chest.15-0300  0.282
2006 Klinger JR, Thaker S, Houtchens J, Preston IR, Hill NS, Farber HW. Pulmonary hemodynamic responses to brain natriuretic peptide and sildenafil in patients with pulmonary arterial hypertension. Chest. 129: 417-25. PMID 16478861 DOI: 10.1378/chest.129.2.417  0.281
2012 Kitterman N, Poms A, Miller DP, Lombardi S, Farber HW, Barst RJ. Bloodstream infections in patients with pulmonary arterial hypertension treated with intravenous prostanoids: insights from the REVEAL REGISTRY®. Mayo Clinic Proceedings. 87: 825-34. PMID 22883740 DOI: 10.1016/j.mayocp.2012.05.014  0.28
2009 Oudiz RJ, Farber HW. Dosing considerations in the use of intravenous prostanoids in pulmonary arterial hypertension: an experience-based review. American Heart Journal. 157: 625-35. PMID 19332188 DOI: 10.1016/j.ahj.2008.10.029  0.28
2013 Sadoughi A, Roberts KE, Preston IR, Lai GP, McCollister DH, Farber HW, Hill NS. Use of selective serotonin reuptake inhibitors and outcomes in pulmonary arterial hypertension. Chest. 144: 531-41. PMID 23558791 DOI: 10.1378/chest.12-2081  0.277
2012 Farber HW. Validation of the 6-minute walk in patients with pulmonary arterial hypertension: trying to fit a square PEG into a round hole? Circulation. 126: 258-60. PMID 22696078 DOI: 10.1161/CIRCULATIONAHA.112.118547  0.277
2014 Farber HW, Miller DP. Cause of death in patients with pulmonary arterial hypertension. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 33: 222. PMID 24365766 DOI: 10.1016/j.healun.2013.10.025  0.276
2013 Farber HW, Miller DP, Meltzer LA, McGoon MD. Treatment of patients with pulmonary arterial hypertension at the time of death or deterioration to functional class IV: insights from the REVEAL Registry. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 32: 1114-22. PMID 24035189 DOI: 10.1016/j.healun.2013.08.010  0.274
2006 Tam DH, Farber HW. Pulmonary hypertension and beta-thalassemia major: report of a case, its treatment, and a review of the literature. American Journal of Hematology. 81: 443-7. PMID 16680745 DOI: 10.1002/ajh.20603  0.272
2010 Farber HW, Walkey AJ, O'Donnell MR. Ethical issues associated with globalization of placebo-controlled in pulmonary arterial hypertension. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 29: 825-6. PMID 20456982 DOI: 10.1016/j.healun.2010.03.010  0.271
2010 Pendergrass SA, Hayes E, Farina G, Lemaire R, Farber HW, Whitfield ML, Lafyatis R. Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury. Plos One. 5: e12106. PMID 20808962 DOI: 10.1371/Journal.Pone.0012106  0.269
2015 Sardana M, Moll M, Farber HW. Novel investigational therapies for treating pulmonary arterial hypertension. Expert Opinion On Investigational Drugs. 1-26. PMID 26484967 DOI: 10.1517/13543784.2015.1098616  0.268
2019 Thakur N, Borrell LN, Ye M, Oh SS, Eng C, Meade K, Avila PC, Farber HJ, Serebrisky D, Brigino-Buenaventura E, Rodriguez-Cintron W, Kumar R, Bibbins-Domingo K, Thyne S, Sen S, et al. Acculturation is Associated with Asthma Burden and Pulmonary Function in Latino Youth: The GALA II Study. The Journal of Allergy and Clinical Immunology. PMID 30682453 DOI: 10.1016/J.Jaci.2018.12.1015  0.266
2011 York M, Farber HW. Pulmonary hypertension: screening and evaluation in scleroderma. Current Opinion in Rheumatology. 23: 536-44. PMID 21934501 DOI: 10.1097/BOR.0b013e32834ba6a7  0.265
2010 Fiack CA, Farber HW. Pulmonary hypertension associated with left ventricular diastolic dysfunction. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 29: 230-1. PMID 20113913 DOI: 10.1016/j.healun.2009.07.014  0.264
2013 Poms AD, Turner M, Farber HW, Meltzer LA, McGoon MD. Comorbid conditions and outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis. Chest. 144: 169-76. PMID 23348820 DOI: 10.1378/chest.11-3241  0.261
2008 McGoon MD, Krichman A, Farber HW, Barst RJ, Raskob GE, Liou TG, Miller DP, Feldkircher K, Giles S. Design of the REVEAL registry for US patients with pulmonary arterial hypertension. Mayo Clinic Proceedings. 83: 923-31. PMID 18674477 DOI: 10.4065/83.8.923  0.261
2015 Frantz RP, Schilz RJ, Chakinala MM, Badesch DB, Frost AE, McLaughlin VV, Barst RJ, Rosenberg DM, Miller DP, Hartline BK, Benton WW, Farber HW. Hospitalization and survival in patients using epoprostenol for injection in the PROSPECT observational study. Chest. 147: 484-94. PMID 25320967 DOI: 10.1378/chest.14-1004  0.26
2013 Miller DP, Farber HW. "Who'll be the next in line?" The lung allocation score in patients with pulmonary arterial hypertension. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 32: 1165-7. PMID 24210050 DOI: 10.1016/j.healun.2013.10.004  0.258
2014 Hellawell JL, Bhattacharya S, Farber HW. Pharmacokinetic evaluation of treprostinil (oral) for the treatment of pulmonary arterial hypertension. Expert Opinion On Drug Metabolism & Toxicology. 10: 1445-53. PMID 25204984 DOI: 10.1517/17425255.2014.958466  0.257
2011 Schilz R, Farber HW. Quality initiatives and models of care in patients with pulmonary arterial hypertension: the time has come! International Journal of Clinical Practice. Supplement. 1-3. PMID 22171815 DOI: 10.1111/j.1742-1241.2011.02835.x  0.254
2007 Miller NS, Dobre MC, Liebschutz JM, Williams TC, Orr BL, Farber HW. Micrococcus bacteremia in a patient with pulmonary hypertension and a long-term central venous catheter: Opportunity knocks, and an unexpected pathogen enters Clinical Microbiology Newsletter. 29: 173-175. DOI: 10.1016/j.clinmicnews.2007.10.005  0.252
2009 Summer R, Fiack CA, Ikeda Y, Sato K, Dwyer D, Ouchi N, Fine A, Farber HW, Walsh K. Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease. American Journal of Physiology. Lung Cellular and Molecular Physiology. 297: L432-8. PMID 19561137 DOI: 10.1152/Ajplung.90599.2008  0.251
2015 Waxman AB, Farber HW. Using Clinical Trial End Points to Risk Stratify Patients With Pulmonary Arterial Hypertension. Circulation. 132: 2152-61. PMID 26621638 DOI: 10.1161/CIRCULATIONAHA.114.012328  0.251
2015 Sitbon O, Benza RL, Badesch DB, Barst RJ, Elliott CG, Gressin V, Lemarié JC, Miller DP, Muros-Le Rouzic E, Simonneau G, Frost AE, Farber HW, Humbert M, McGoon MD. Validation of two predictive models for survival in pulmonary arterial hypertension. The European Respiratory Journal. 46: 152-64. PMID 25837032 DOI: 10.1183/09031936.00004414  0.251
2001 Klings ES, Farber HW. Current Management of Primary Pulmonary Hypertension Drugs. 61: 1945-1956. PMID 11708765  0.247
2011 Christmann RB, Hayes E, Pendergrass S, Padilla C, Farina G, Affandi AJ, Whitfield ML, Farber HW, Lafyatis R. Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-associated pulmonary arterial hypertension. Arthritis and Rheumatism. 63: 1718-28. PMID 21425123 DOI: 10.1002/Art.30318  0.247
2015 Farber HW, Miller DP, McGoon MD, Frost AE, Benton WW, Benza RL. Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 34: 362-8. PMID 25312386 DOI: 10.1016/j.healun.2014.08.020  0.245
2014 Chung L, Farber HW, Benza R, Miller DP, Parsons L, Hassoun PM, McGoon M, Nicolls MR, Zamanian RT. Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry. Chest. 146: 1494-504. PMID 24992469 DOI: 10.1378/chest.13-3014  0.241
2011 Farber HW, Foreman AJ, Miller DP, McGoon MD. REVEAL Registry: correlation of right heart catheterization and echocardiography in patients with pulmonary arterial hypertension. Congestive Heart Failure (Greenwich, Conn.). 17: 56-64. PMID 21449993 DOI: 10.1111/j.1751-7133.2010.00202.x  0.24
2010 Lazar HL, Farber HW. Acute pulmonary embolism. The New England Journal of Medicine. 363: 1974; author reply 1. PMID 21067400 DOI: 10.1056/NEJMc1009061#SA6  0.239
2009 Petcu EB, Berman L, Opris MM, Gheorghiu V, Kessler SC, Hayes J, Farber HW. Pulmonary hypertension in systemic Lupus Erythematosus complicated by exposure to Dexfenfluramine Romanian Journal of Legal Medicine. 17: 83-88. DOI: 10.4323/rjlm.2009.83  0.239
2010 Lazar HL, Farber HW. Early pulmonary embolectomy for acute pulmonary embolus: an operation whose time has come. Journal of Cardiac Surgery. 25: 259-60. PMID 20202028 DOI: 10.1111/j.1540-8191.2010.01012.x  0.238
2015 Farber HW, Gibbs S. Under pressure: pulmonary hypertension associated with left heart disease. European Respiratory Review : An Official Journal of the European Respiratory Society. 24: 665-73. PMID 26621980 DOI: 10.1183/16000617.0059-2015  0.236
2005 Klinger JR, Houtchens J, Thaker S, Hill NS, Farber H. Acute cardiopulmonary hemodynamic effects of brain natriuretic peptide in patients with pulmonary arterial hypertension. Chest. 128: 618S-619S. PMID 16373873 DOI: 10.1378/chest.128.6_suppl.618S-a  0.235
2004 Klings ES, Farber HW, Hassoun PM, Krishnan JA, Gladwin MT, Sachdev V, Ognibene FP. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease [3] (multiple letters) New England Journal of Medicine. 350: 2521-2522. PMID 15195345 DOI: 10.1056/NEJM200406103502418  0.233
2011 Frost AE, Badesch DB, Barst RJ, Benza RL, Elliott CG, Farber HW, Krichman A, Liou TG, Raskob GE, Wason P, Feldkircher K, Turner M, McGoon MD. The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries. Chest. 139: 128-37. PMID 20558556 DOI: 10.1378/Chest.10-0075  0.233
2015 McEvoy CA, Sardana M, Moll M, Farber HW, Chakinala MM. Patient registries in pulmonary arterial hypertension: The role of survival equations and risk calculators Pulmonary Hypertension: Basic Science to Clinical Medicine. 307-325. DOI: 10.1007/978-3-319-23594-3_20  0.233
2015 Pbert L, Farber H, Horn K, Lando HA, Muramoto M, O'Loughlin J, Tanski S, Wellman RJ, Winickoff JP, Klein JD. State-of-the-art office-based interventions to eliminate youth tobacco use: the past decade. Pediatrics. 135: 734-47. PMID 25780075 DOI: 10.1542/Peds.2014-2037  0.23
2015 Henriques-Forsythe M, Annangi S, Farber HW. Prevalence and hospital discharge status of human immunodeficiency virus-associated pulmonary arterial hypertension in the United States. Pulmonary Circulation. 5: 506-12. PMID 26401251 DOI: 10.1086/682222  0.229
2012 Farber HW. Pulmonary arterial hypertension in patients with HIV infection European Respiratory Monograph. 57: 82-93. DOI: 10.1183/1025448x.10019011  0.223
2014 Bradford MA, Farber HW. Are we correctly defining intermediate-risk pulmonary embolism? Chest. 146: e169. PMID 25367487 DOI: 10.1378/chest.14-1362  0.222
2015 Grossman NL, Fiack CA, Weinberg JM, Rybin DV, Farber HW. Pulmonary hypertension associated with heart failure with preserved ejection fraction: acute hemodynamic effects of inhaled iloprost. Pulmonary Circulation. 5: 198-203. PMID 25992282 DOI: 10.1086/679725  0.222
2011 Brown LM, Chen H, Halpern S, Taichman D, McGoon MD, Farber HW, Frost AE, Liou TG, Turner M, Feldkircher K, Miller DP, Elliott CG. Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry. Chest. 140: 19-26. PMID 21393391 DOI: 10.1378/Chest.10-1166  0.222
2003 Klings ES, Farber HW. The pathogenesis of HIV-associated pulmonary hypertension Advances in Cardiology. 40: 71-82. PMID 14533547  0.221
2003 Burkart KM, Farber HW. HIV-associated pulmonary hypertension: Diagnosis and treatment Advances in Cardiology. 40: 197-207. PMID 14533555  0.219
2015 Shah NP, Wallis N, Farber HW, Mauro MJ, Wolf RA, Mattei D, Guha M, Rea D, Peacock A. Clinical features of pulmonary arterial hypertension in patients receiving dasatinib. American Journal of Hematology. 90: 1060-4. PMID 26284693 DOI: 10.1002/Ajh.24174  0.214
2010 Hardy H, Backman ES, Farber HW. Successful bosentan and nonnucleoside reverse transcriptase inhibitor-based therapy in a patient with acquired immunodeficiency syndrome and pulmonary arterial hypertension. Pharmacotherapy. 30: 139e-44e. PMID 20334465 DOI: 10.1592/phco.30.4.422  0.211
2009 McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. Journal of the American College of Cardiology. 53: 1573-619. PMID 19389575 DOI: 10.1016/J.Jacc.2009.01.004  0.199
2021 Lee SA, Sayad E, Yenduri NJS, Wang KY, Guillerman RP, Farber HJ. Improvement in Pulmonary Function Following Discontinuation of Vaping or E-Cigarette Use in Adolescents with EVALI. Pediatric Allergy, Immunology, and Pulmonology. 34: 23-29. PMID 33734875 DOI: 10.1089/ped.2020.1270  0.199
2015 Farber HJ, Batsell RR, Silveira EA, Calhoun RT, Giardino AP. The Impact of Tobacco Smoke Exposure on Childhood Asthma in a Medicaid Managed Care Plan. Chest. PMID 26512943 DOI: 10.1378/chest.15-1378  0.197
2010 Farber HW, Simms RW, Lafyatis R. Care of patients with scleroderma in the intensive care setting. Journal of Intensive Care Medicine. 25: 247-58. PMID 20542965 DOI: 10.1177/0885066610371181  0.197
1998 Farber HJ, Johnson C, Beckerman RC. Young inner-city children visiting the emergency room (ER) for asthma: risk factors and chronic care behaviors. The Journal of Asthma : Official Journal of the Association For the Care of Asthma. 35: 547-52. PMID 9777881  0.195
2002 Lieu TA, Lozano P, Finkelstein JA, Chi FW, Jensvold NG, Capra AM, Quesenberry CP, Selby JV, Farber HJ. Racial/ethnic variation in asthma status and management practices among children in managed medicaid. Pediatrics. 109: 857-65. PMID 11986447 DOI: 10.1542/peds.109.5.857  0.193
2015 Hill NS, Badesch D, Benza RL, D'Eletto TA, Farber HW, Gomberg-Maitland M, Hassoun PM, Preston I. Reply: Perspectives on Oral Pulmonary Hypertension Therapies Recently Approved by the U.S. Food and Drug Administration. Annals of the American Thoracic Society. 12: 960. PMID 26075562 DOI: 10.1513/AnnalsATS.201505-263LE  0.188
2008 Klings ES, Anton Bland D, Rosenman D, Princeton S, Odhiambo A, Li G, Bernard SA, Steinberg MH, Farber HW. Pulmonary arterial hypertension and left-sided heart disease in sickle cell disease: clinical characteristics and association with soluble adhesion molecule expression. American Journal of Hematology. 83: 547-53. PMID 18383329 DOI: 10.1002/ajh.21187  0.188
2017 Farber HJ, Silveira EA, Vicere DR, Kothari VD, Giardino AP. Oral Corticosteroid Prescribing for Children With Asthma in a Medicaid Managed Care Program. Pediatrics. 139. PMID 28557753 DOI: 10.1542/peds.2016-4146  0.186
2012 Oh SS, Tcheurekdjian H, Roth LA, Nguyen EA, Sen S, Galanter JM, Davis A, Farber HJ, Gilliland FD, Kumar R, Avila PC, Brigino-Buenaventura E, Chapela R, Ford JG, LeNoir MA, et al. Effect of secondhand smoke on asthma control among black and Latino children. The Journal of Allergy and Clinical Immunology. 129: 1478-83.e7. PMID 22552109 DOI: 10.1016/J.Jaci.2012.03.017  0.184
2009 McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J, Harrington RA, Anderson JL, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation. 119: 2250-94. PMID 19332472 DOI: 10.1161/Circulationaha.109.192230  0.183
2011 Wilson SR, Farber HJ, Knowles SB, Lavori PW. A randomized trial of parental behavioral counseling and cotinine feedback for lowering environmental tobacco smoke exposure in children with asthma: results of the LET'S Manage Asthma trial. Chest. 139: 581-90. PMID 20864611 DOI: 10.1378/chest.10-0772  0.182
2009 Farber HJ. Care management for childhood asthma: What works? Pediatric Asthma, Allergy and Immunology. 22: 105-110. DOI: 10.1089/pai.2009.0014  0.181
2015 Hill NS, Badesch D, Benza RL, D'Eletto TA, Farber HW, Gomberg-Maitland M, Hassoun PM, Preston I. Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. Food and Drug Administration. Annals of the American Thoracic Society. 12: 269-73. PMID 25590376 DOI: 10.1513/AnnalsATS.201501-020AS  0.178
2020 Farber HJ, Phillips WA, Kocab KL, Hanson DS, Heydemann JA, Dahl BT, Spoede ET, Jefferson LS. Impact of scoliosis surgery on pulmonary function in patients with muscular dystrophies and spinal muscular atrophy. Pediatric Pulmonology. PMID 32012473 DOI: 10.1002/ppul.24664  0.177
2015 Pino-Yanes M, Thakur N, Gignoux CR, Galanter JM, Roth LA, Eng C, Nishimura KK, Oh SS, Vora H, Huntsman S, Nguyen EA, Hu D, Drake KA, Conti DV, Moreno-Estrada A, ... ... Farber HJ, et al. Genetic ancestry influences asthma susceptibility and lung function among Latinos. The Journal of Allergy and Clinical Immunology. 135: 228-35. PMID 25301036 DOI: 10.1016/J.Jaci.2014.07.053  0.174
2020 Wohlford EM, Borrell LN, Elhawary JR, Plotkin B, Oh SS, Nuckton TJ, Eng C, Salazar S, LeNoir MA, Meade K, Farber HJ, Serebrisky D, Brigino-Buenaventura E, Rodriguez-Cintron W, Kumar R, et al. Differential asthma odds following respiratory infection in children from three minority populations. Plos One. 15: e0231782. PMID 32369487 DOI: 10.1371/Journal.Pone.0231782  0.174
2019 Samedy-Bates LA, Oh SS, Nuckton TJ, Elhawary JR, White M, Elliot T, Zeiger AM, Eng C, Salazar S, LeNoir MA, Meade K, Farber HJ, Serebrisky D, Brigino-Buenaventura E, Rodriguez-Cintron W, et al. Racial/ethnic-specific differences in the effects of inhaled corticosteroid use on bronchodilator response in patients with asthma. Clinical Pharmacology and Therapeutics. PMID 31209858 DOI: 10.1002/Cpt.1555  0.173
2009 Safaya S, Klings ES, Odhiambo A, Li G, Farber HW, Steinberg MH. Effect of sodium butyrate on lung vascular TNFSF15 (TL1A) expression: differential expression patterns in pulmonary artery and microvascular endothelial cells. Cytokine. 46: 72-8. PMID 19251437 DOI: 10.1016/j.cyto.2008.12.013  0.171
2016 Oh S, Du R, Zeiger AM, Mcgarry ME, Hu D, Thakur N, Pino-Yanes M, Galanter JM, Farber HJ, Eng C, Nishimura KK, Huntsman S, Meade K, Avila P, Serebrisky D, et al. Breastfeeding associated with higher lung function in African American youths with asthma. The Journal of Asthma : Official Journal of the Association For the Care of Asthma. 0. PMID 27929698 DOI: 10.1080/02770903.2016.1266496  0.168
2001 Wittram C, Fogg J, Farber H. Immune restoration syndrome manifested by pulmonary sarcoidosis American Journal of Roentgenology. 177: 1427. PMID 11717100  0.165
2007 Odhiambo A, Perlman DH, Huang H, Costello CE, Farber HW, Steinberg MH, McComb ME, Klings ES. Identification of oxidative post-translational modification of serum albumin in patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension of sickle cell anemia. Rapid Communications in Mass Spectrometry : Rcm. 21: 2195-203. PMID 17569101 DOI: 10.1002/Rcm.3074  0.164
2013 Lenna S, Farina AG, Martyanov V, Christmann RB, Wood TA, Farber HW, Scorza R, Whitfield ML, Lafyatis R, Trojanowska M. Increased expression of endoplasmic reticulum stress and unfolded protein response genes in peripheral blood mononuclear cells from patients with limited cutaneous systemic sclerosis and pulmonary arterial hypertension. Arthritis and Rheumatism. 65: 1357-66. PMID 23400395 DOI: 10.1002/Art.37891  0.164
2023 Farber HJ, Silveira E, Wong JY. An assessment of the predictive value of low risk criteria for children with intermittent asthma. Pediatric Pulmonology. PMID 36814331 DOI: 10.1002/ppul.26369  0.164
2022 Nair AA, Farber HJ, Chen H. Risk of asthma exacerbation associated with opioid and nonopioid analgesic use in children with current asthma. Journal of Managed Care & Specialty Pharmacy. 28: 325-335. PMID 35199576 DOI: 10.18553/jmcp.2022.28.3.325  0.163
2006 Ieong MH, Farber HW. Noninfectious pulmonary complications of HIV Clinical Pulmonary Medicine. 13: 194-202. DOI: 10.1097/01.cpm.0000218606.74161.d4  0.163
1997 Farber HJ, Wattigney W, Berenson G. Trends in asthma prevalence: the Bogalusa Heart Study. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. 78: 265-9. PMID 9087150 DOI: 10.1016/S1081-1206(10)63179-1  0.163
2017 Sherenian MG, Cho SH, Levin AM, Min JY, Sen S, Oh S, Huntsman S, Eng C, Farber HJ, Rodriguez-Cintron W, Rodriguez-Santana JR, Serebrisky D, Borrell L, Williams LK, Thyne S, et al. Title: PAI-1 Gain of Function Genotype and Airway Obstruction in Asthma Journal of Allergy and Clinical Immunology. 139: AB171. DOI: 10.1016/J.Jaci.2016.12.562  0.163
2004 Lieu TA, Finkelstein JA, Lozano P, Capra AM, Chi FW, Jensvold N, Quesenberry CP, Farber HJ. Cultural competence policies and other predictors of asthma care quality for Medicaid-insured children. Pediatrics. 114: e102-10. PMID 15231981  0.163
2013 Machado RF, Farber HW. Pulmonary hypertension associated with chronic hemolytic anemia and other blood disorders. Clinics in Chest Medicine. 34: 739-52. PMID 24267302 DOI: 10.1016/j.ccm.2013.08.006  0.162
2002 Finkelstein JA, Lozano P, Farber HJ, Miroshnik I, Lieu TA. Underuse of controller medications among Medicaid-insured children with asthma. Archives of Pediatrics & Adolescent Medicine. 156: 562-7. PMID 12038888  0.161
2016 Thakur N, Barcelo NE, Borrell LN, Singh S, Eng C, Davis A, Meade K, LeNoir MA, Avila PC, Farber HJ, Serebrisky D, Brigino-Buenaventura E, Rodriguez-Cintron W, Thyne S, Rodriguez-Santana JR, et al. Perceived Discrimination Associated with Asthma and Related Outcomes in Minority Youth: The GALA II and SAGE II Studies. Chest. PMID 27916618 DOI: 10.1016/J.Chest.2016.11.027  0.16
2004 Farber HJ, Chi FW, Capra A, Jensvold NG, Finkelstein JA, Lozano P, Quesenberry CP, Lieu TA. Use of asthma medication dispensing patterns to predict risk of adverse health outcomes: a study of Medicaid-insured children in managed care programs. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. 92: 319-28. PMID 15049395 DOI: 10.1016/S1081-1206(10)61569-4  0.159
2014 Bhargave G, Hsu J, Nguyen E, Roth L, Galanter J, Oh S, Eng C, Lurmann F, Farber HJ, Serebrisky D, Borrell L, Sen S, Rodriguez-Cintron W, Rodriguez-Santana J, Burchard EG, et al. Nocturnal Asthma In Latino Children Is Associated With Severe Disease and Allergenic Triggers (GALA II Study) Journal of Allergy and Clinical Immunology. 133: AB81. DOI: 10.1016/J.Jaci.2013.12.311  0.159
2018 Neophytou AM, Oh SS, White MJ, Mak ACY, Hu D, Huntsman S, Eng C, Serebrisky D, Borrell LN, Farber HJ, Meade K, Davis A, Avila PC, Thyne SM, Rodríguez-Cintrón W, et al. Secondhand smoke exposure and asthma outcomes among African-American and Latino children with asthma. Thorax. PMID 29899038 DOI: 10.1136/Thoraxjnl-2017-211383  0.158
2016 Fishbein AB, Lee TA, Cai M, Oh SS, Eng C, Hu D, Huntsman S, Farber HJ, Serebrisky D, Silverberg J, Williams LK, Seibold MA, Sen S, Borrell LN, Avila P, et al. Sensitization to mouse and cockroach allergens and asthma morbidity in urban minority youth: Genes-environments and Admixture in Latino American (GALA-II) and Study of African-Americans, Asthma, Genes, and Environments (SAGE-II). Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. PMID 27238578 DOI: 10.1016/J.Anai.2016.05.004  0.157
2003 Lozano P, Grothaus LC, Finkelstein JA, Hecht J, Farber HJ, Lieu TA. Variability in asthma care and services for low-income populations among practice sites in managed Medicaid systems. Health Services Research. 38: 1563-78. PMID 14727788  0.157
2013 Nishimura KK, Galanter JM, Roth LA, Oh SS, Thakur N, Nguyen EA, Thyne S, Farber HJ, Serebrisky D, Kumar R, Brigino-Buenaventura E, Davis A, LeNoir MA, Meade K, Rodriguez-Cintron W, et al. Early-life air pollution and asthma risk in minority children. The GALA II and SAGE II studies. American Journal of Respiratory and Critical Care Medicine. 188: 309-18. PMID 23750510 DOI: 10.1164/Rccm.201302-0264Oc  0.157
2019 Hernandez-Pacheco N, Farzan N, Francis B, Karimi L, Repnik K, Vijverberg SJ, Soares P, Schieck M, Gorenjak M, Forno E, Eng C, S Oh S, Pérez-Méndez L, Berce V, Tavendale R, ... ... Farber HJ, et al. Genome-wide association study of inhaled corticosteroid response in admixed children with asthma. Clinical and Experimental Allergy : Journal of the British Society For Allergy and Clinical Immunology. PMID 30697902 DOI: 10.1111/Cea.13354  0.155
2014 Thakur N, Martin M, Castellanos E, Oh SS, Roth LA, Eng C, Brigino-Buenaventura E, Davis A, Meade K, LeNoir MA, Farber HJ, Thyne S, Sen S, Bibbins-Domingo K, Borrell LN, et al. Socioeconomic status and asthma control in African American youth in SAGE II. The Journal of Asthma : Official Journal of the Association For the Care of Asthma. 51: 720-8. PMID 24654704 DOI: 10.3109/02770903.2014.905593  0.153
2001 Wittram C, Fogg J, Farber H. Radiologic-pathologic conferences of Boston University Medical Center: Immune restoration syndrome manifested by pulmonary sarcoidosis American Journal of Roentgenology. 177: 1427.  0.152
2019 Raun L, Persse D, Johnson G, Ensor K, Stevenson E, Valerio MA, Caton EK, Campos L, Farber HJ. Using Complex, Multi-Sectoral Data in a Needs Assessment to Inform Future Strategies in Childhood Asthma Management Health Behavior Research. 2. DOI: 10.4148/2572-1836.1037  0.152
2009 Farber HJ, Abramson SL, Polosa R. Editorial: Pediatric asthma, allergy & immunology will be changing its name to pediatric allergy, immunology, & pulmonology Pediatric Asthma, Allergy and Immunology. 22: 133. DOI: 10.1089/pai.2009.2204.edi  0.15
2013 Borrell LN, Nguyen EA, Roth LA, Oh SS, Tcheurekdjian H, Sen S, Davis A, Farber HJ, Avila PC, Brigino-Buenaventura E, Lenoir MA, Lurmann F, Meade K, Serebrisky D, Rodriguez-Cintron W, et al. Childhood obesity and asthma control in the GALA II and SAGE II studies. American Journal of Respiratory and Critical Care Medicine. 187: 697-702. PMID 23392439 DOI: 10.1164/Rccm.201211-2116Oc  0.149
2016 Neophytou AM, White MJ, Oh SS, Thakur N, Galanter JM, Nishimura KK, Pino-Yanes M, Torgerson DG, Gignoux CR, Eng C, Nguyen EA, Hu D, Mak AC, Kumar R, Seibold MA, ... ... Farber HJ, et al. Air Pollution and Lung Function in Minority Youth with Asthma in the GALA II & SAGE II Studies. American Journal of Respiratory and Critical Care Medicine. PMID 26734713 DOI: 10.1164/Rccm.201508-1706Oc  0.149
2018 Mak AC, White MJ, Eckalbar WL, Szpiech ZA, Oh SS, Pino-Yanes M, Hu D, Goddard P, Huntsman S, Galanter J, Wu AC, Himes BE, Germer S, Vogel JM, Bunting KL, ... ... Farber HJ, et al. Whole Genome Sequencing of Pharmacogenetic Drug Response in Racially Diverse Children with Asthma. American Journal of Respiratory and Critical Care Medicine. PMID 29509491 DOI: 10.1164/Rccm.201712-2529Oc  0.148
2016 Cho SH, Min JY, Kim DY, Oh SS, Torgerson DR, Pino-Yanes M, Hu D, Sen S, Huntsman S, Eng C, Farber HJ, Rodriguez-Cintron W, Rodriguez-Santana JR, Serebrisky D, Thyne SM, et al. Association of a PAI-1 Gene Polymorphism and Early Life Infections with Asthma Risk, Exacerbations, and Reduced Lung Function. Plos One. 11: e0157848. PMID 27556405 DOI: 10.1371/Journal.Pone.0157848  0.148
2015 Fenny NS, Nguyen E, Galanter J, Oh S, Eng C, Lurmann F, Kumar R, Farber HJ, Serebrisky D, Borrell L, Sen S, Rodriguez-Cintron W, Rodriguez-Santana J, Burchard EG, Avila PC. Association Between Acetaminophen and Asthma Morbidity in a Latino Population Journal of Allergy and Clinical Immunology. 135: AB236. DOI: 10.1016/J.Jaci.2014.12.1707  0.148
2015 McGarry ME, Castellanos E, Thakur N, Oh SS, Eng C, Davis A, Meade K, LeNoir MA, Avila PC, Farber HJ, Serebrisky D, Brigino-Buenaventura E, Rodriguez-Cintron W, Kumar R, Bibbins-Domingo K, et al. Obesity and bronchodilator response in black and Hispanic children and adolescents with asthma. Chest. 147: 1591-8. PMID 25742612 DOI: 10.1378/Chest.14-2689  0.144
2018 Gignoux CR, Torgerson DG, Pino-Yanes M, Uricchio LH, Galanter J, Roth LA, Eng C, Hu D, Nguyen EA, Huntsman S, Mathias RA, Kumar R, Rodriguez-Santana J, Thakur N, Oh SS, ... ... Farber HJ, et al. An admixture mapping meta-analysis implicates genetic variation at 18q21 with asthma susceptibility in Latinos. The Journal of Allergy and Clinical Immunology. PMID 30201514 DOI: 10.1016/J.Jaci.2016.08.057  0.144
2010 Farber HJ. Optimizing maintenance therapy in pediatric asthma. Current Opinion in Pulmonary Medicine. 16: 25-30. PMID 19904206 DOI: 10.1097/MCP.0b013e3283339962  0.142
2000 FARBER HJ, BUDSON D. A Pediatric Case of Severe Chronic Interstitial Lung Disease Presenting as Spontaneous Pneumothorax: Blame It on the Birds Pediatric Asthma, Allergy & Immunology. 14: 75-85. DOI: 10.1089/PAI.2000.14.75  0.141
2013 Hsu J, Burley U, Nguyen E, Roth L, Galanter J, Oh S, Eng C, Lurmann F, Kumar R, Farber HJ, Serebrisky D, Borrell L, Sen S, Rodriguez-Cintron W, Rodriguez-Santana J, et al. Aeroallergen Sensitization Is Associated with Asthma Severity in Latinos (GALA-II Study) Journal of Allergy and Clinical Immunology. 131: AB51. DOI: 10.1016/J.Jaci.2012.12.866  0.14
2006 Farber HJ, Glauber J. Combination therapy for asthma: Perspectives of the patient, provider, and payer Disease Management and Health Outcomes. 14: 353-368. DOI: 10.2165/00115677-200614060-00005  0.139
2013 Thakur N, Oh SS, Nguyen EA, Martin M, Roth LA, Galanter J, Gignoux CR, Eng C, Davis A, Meade K, LeNoir MA, Avila PC, Farber HJ, Serebrisky D, Brigino-Buenaventura E, et al. Socioeconomic status and childhood asthma in urban minority youths. The GALA II and SAGE II studies. American Journal of Respiratory and Critical Care Medicine. 188: 1202-9. PMID 24050698 DOI: 10.1164/Rccm.201306-1016Oc  0.139
2018 Spear ML, Hu D, Pino-Yanes M, Huntsman S, Eng C, Levin AM, Ortega VE, White MJ, McGarry ME, Thakur N, Galanter J, Mak ACY, Oh SS, Ampleford E, Peters SP, ... ... Farber HJ, et al. A genome-wide association and admixture mapping study of bronchodilator drug response in African Americans with asthma. The Pharmacogenomics Journal. PMID 30206298 DOI: 10.1038/S41397-018-0042-4  0.137
2016 Nishimura KK, Iwanaga K, Oh SS, Pino-Yanes M, Eng C, Keswani A, Roth LA, Nguyen EA, Thyne SM, Farber HJ, Serebrisky D, Meade K, LeNoir MA, Rodriguez-Cintron W, Borrell LN, et al. Early-life ozone exposure associated with asthma without sensitization in Latino children. The Journal of Allergy and Clinical Immunology. PMID 27423496 DOI: 10.1016/J.Jaci.2016.03.058  0.137
2016 Farber HJ. Point: Is escalation of the inhaled corticosteroid dose appropriate for acute loss of asthma control in an attempt to reduce need for oral corticosteroids in children? Yes. Chest. PMID 27426479 DOI: 10.1016/j.chest.2016.06.024  0.136
2020 Leone FT, Zhang Y, Evers-Casey S, Evins AE, Eakin MN, Fathi J, Fennig K, Folan P, Galiatsatos P, Gogineni H, Kantrow S, Kathuria H, Lamphere T, Neptune E, Pacheco MC, ... ... Farber HJ, et al. Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine. 202: e5-e31. PMID 32663106 DOI: 10.1164/Rccm.202005-1982St  0.136
2013 Burley U, Hsu J, Nguyen E, Roth L, Galanter J, Oh S, Eng C, Lurmann F, Kumar R, Farber HJ, Serebrisky D, Borrell L, Sen S, Rodriguez-Cintron W, Rodriguez-Santana J, et al. Contributing and Protective Risk Factors for Asthma Exacerbation in Latinos (GALA-II Study) Journal of Allergy and Clinical Immunology. 131: AB51. DOI: 10.1016/J.Jaci.2012.12.865  0.135
2022 Farber HJ, Silveira EA, Moore R, Sockrider MM. Evaluation of a pediatric asthma high-risk scoring algorithm. The American Journal of Managed Care. 28: 254-260. PMID 35738221 DOI: 10.37765/ajmc.2022.88788  0.135
2023 Cole M, Raphael J, Katkin JP, Yenduri NJS, Gazzaneo MC, Revana A, Anagnostou A, Farber HJ. Asthma Outcomes in Pediatric Patients with 30-day Follow-up after an Asthma Hospitalization in a Medicaid-managed Care Program. The Journal of Asthma : Official Journal of the Association For the Care of Asthma. 1-13. PMID 36893220 DOI: 10.1080/02770903.2023.2185155  0.134
2016 Rajesh K, Cho SH, Min JY, Kang J, Chan W, Kim D, Oh S, Torgerson D, Del-Pino-Yanes MdM, Hu D, Sen S, Huntsman S, Eng C, Farber HJ, Rodriguez-Cintron W, et al. PAI-1, Early Life Infections and Asthma Risk, Exacerbations, and Reduced Lung Function Journal of Allergy and Clinical Immunology. 137: AB178. DOI: 10.1016/J.Jaci.2015.12.717  0.134
2010 Walkey AJ, Farber HW, O'Donnell C, Cabral H, Eagan JS, Philippides GJ. The accuracy of the central venous blood gas for acid-base monitoring. Journal of Intensive Care Medicine. 25: 104-10. PMID 20018607 DOI: 10.1177/0885066609356164  0.132
2001 Glauber JH, Farber HJ, Homer CJ. Asthma clinical pathways: toward what end? Pediatrics. 107: 590-2. PMID 11230605 DOI: 10.1542/PEDS.107.3.590  0.131
2014 Regan JA, Hsu J, Nguyen E, Roth L, Galanter J, Oh S, Eng C, Lurmann F, Kumar R, Farber HJ, Serebrisky D, Borrell L, Sen S, Rodriguez-Cintron W, Rodriguez-Santana J, et al. Sinusitis In Latino Children Is Associated With Allergic Respiratory Diseases and Inversely Related To Native American Ancestry (GALA II Study) Journal of Allergy and Clinical Immunology. 133: AB130. DOI: 10.1016/J.Jaci.2013.12.482  0.131
2008 Farber HJ, Knowles SB, Brown NL, Caine L, Luna V, Qian Y, Lavori P, Wilson SR. Secondhand tobacco smoke in children with asthma: sources of and parental perceptions about exposure in children and parental readiness to change. Chest. 133: 1367-74. PMID 18339788 DOI: 10.1378/chest.07-2369  0.131
2006 Gnanasekaran SK, Finkelstein JA, Lozano P, Farber HJ, Chi FW, Lieu TA. Influenza vaccination among children with asthma in medicaid managed care. Ambulatory Pediatrics : the Official Journal of the Ambulatory Pediatric Association. 6: 1-7. PMID 16443176 DOI: 10.1016/j.ambp.2005.08.004  0.131
2014 Galanter JM, Gignoux CR, Torgerson DG, Roth LA, Eng C, Oh SS, Nguyen EA, Drake KA, Huntsman S, Hu D, Sen S, Davis A, Farber HJ, Avila PC, Brigino-Buenaventura E, et al. Genome-wide association study and admixture mapping identify different asthma-associated loci in Latinos: the Genes-environments & Admixture in Latino Americans study. The Journal of Allergy and Clinical Immunology. 134: 295-305. PMID 24406073 DOI: 10.1016/J.Jaci.2013.08.055  0.13
2003 Farber HJ, Capra AM, Finkelstein JA, Lozano P, Quesenberry CP, Jensvold NG, Chi FW, Lieu TA. Misunderstanding of asthma controller medications: association with nonadherence. The Journal of Asthma : Official Journal of the Association For the Care of Asthma. 40: 17-25. PMID 12699208 DOI: 10.1081/JAS-120017203  0.129
2015 Farber HJ, Groner J, Walley S, Nelson K. Protecting Children From Tobacco, Nicotine, and Tobacco Smoke. Pediatrics. 136: e1439-67. PMID 26504135 DOI: 10.1542/peds.2015-3110  0.126
2014 Drake KA, Torgerson DG, Gignoux CR, Galanter JM, Roth LA, Huntsman S, Eng C, Oh SS, Yee SW, Lin L, Bustamante CD, Moreno-Estrada A, Sandoval K, Davis A, Borrell LN, ... Farber HJ, et al. A genome-wide association study of bronchodilator response in Latinos implicates rare variants. The Journal of Allergy and Clinical Immunology. 133: 370-8. PMID 23992748 DOI: 10.1016/J.Jaci.2013.06.043  0.123
2007 Farber HJ, Schatz M. Health plan employer data and information set (HEDIS®) criteria to determine the quality of asthma care in children: What are the limitations? Disease Management and Health Outcomes. 15: 279-287.  0.122
2007 Farber HJ, Schatz M. Health Plan Employer Data and Information Set (HEDIS®) Criteria to Determine the Quality of Asthma Care in Children Disease Management & Health Outcomes. 15: 279-287. DOI: 10.2165/00115677-200715050-00002  0.121
2024 Nair AA, Placencia JL, Farber HJ, Aparasu RR, Johnson M, Chen H. Pain-related hospitalization and emergency room visit following initial analgesic prescription after outpatient surgery. Pharmacoepidemiology and Drug Safety. 33: e5759. PMID 38357824 DOI: 10.1002/pds.5759  0.12
2015 Lenna S, Assassi S, Farina GA, Mantero JC, Scorza R, Lafyatis R, Farber HW, Trojanowska M. The HLA-B*35 allele modulates ER stress, inflammation and proliferation in PBMCs from Limited Cutaneous Systemic Sclerosis patients. Arthritis Research & Therapy. 17: 363. PMID 26669670 DOI: 10.1186/S13075-015-0881-1  0.117
2016 Abid Z, Oh SS, Hu D, Sen S, Huntsman S, Eng C, Farber HJ, Rodriguez-Cintron W, Rodriguez-Santana JR, Serebrisky D, Avila PC, Thyne SM, Kim KA, Borrell LN, Keoki Williams L, et al. Maternal age and asthma in Latino populations. Clinical and Experimental Allergy : Journal of the British Society For Allergy and Clinical Immunology. PMID 27238356 DOI: 10.1111/Cea.12765  0.116
2005 Farber HJ. High-Quality Asthma Care: It's Not Just About Drugs. The Permanente Journal. 9: 32-6. PMID 22811626  0.115
2013 Kumar R, Nguyen EA, Roth LA, Oh SS, Gignoux CR, Huntsman S, Eng C, Moreno-Estrada A, Sandoval K, Peñaloza-Espinosa RI, López-López M, Avila PC, Farber HJ, Tcheurekdjian H, Rodriguez-Cintron W, et al. Factors associated with degree of atopy in Latino children in a nationwide pediatric sample: the Genes-environments and Admixture in Latino Asthmatics (GALA II) study. The Journal of Allergy and Clinical Immunology. 132: 896-905.e1. PMID 23684070 DOI: 10.1016/J.Jaci.2013.02.046  0.115
2020 Galiatsatos P, Garfield J, Melzer AC, Leone FT, Farber HJ, Ruminjo JK, Thomson CC. Summary for Clinicians: An ATS Clinical Practice Guideline for Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. Annals of the American Thoracic Society. PMID 33052710 DOI: 10.1513/AnnalsATS.202008-971CME  0.114
2004 Finder JD, Birnkrant D, Carl J, Farber HJ, Gozal D, Iannaccone ST, Kovesi T, Kravitz RM, Panitch H, Schramm C, Schroth M, Sharma G, Sievers L, Silvestri JM, Sterni L, et al. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. American Journal of Respiratory and Critical Care Medicine. 170: 456-65. PMID 15302625 DOI: 10.1164/Rccm.200307-885St  0.11
2018 Ferkol TW, Farber HJ, La Grutta S, Leone FT, Marshall HM, Neptune E, Pisinger C, Vanker A, Wisotzky M, Zabert GE, Schraufnagel DE. Electronic cigarette use in youths: a position statement of the Forum of International Respiratory Societies. The European Respiratory Journal. 51. PMID 29848575 DOI: 10.1183/13993003.00278-2018  0.109
2010 Farber HJ. Highlights from this issue of pediatric allergy, immunology, and pulmonology Pediatric, Allergy, Immunology, and Pulmonology. 23: 155-156. DOI: 10.1089/ped.2010.2306  0.109
2010 Wilson SR, Farber HJ. Asthma Education Programs for Children Pediatric Allergy: Principles and Practice Expert Consult: Second Edition. 423-432. DOI: 10.1016/B978-1-4377-0271-2.00039-0  0.108
2004 Farber HJ, Oliveria L. Trial of an asthma education program in an inner-city pediatric emergency department Pediatric Asthma, Allergy and Immunology. 17: 107-115. DOI: 10.1089/0883187041269913  0.106
2012 Myers RA, Himes BE, Gignoux CR, Yang JJ, Gauderman WJ, Rebordosa C, Xie J, Torgerson DG, Levin AM, Baurley J, Graves PE, Mathias RA, Romieu I, Roth LA, Conti D, ... ... Farber HJ, et al. Further replication studies of the EVE Consortium meta-analysis identifies 2 asthma risk loci in European Americans. The Journal of Allergy and Clinical Immunology. 130: 1294-301. PMID 23040885 DOI: 10.1016/J.Jaci.2012.07.054  0.105
2005 Klings ES, Safaya S, Adewoye AH, Odhiambo A, Frampton G, Lenburg M, Gerry N, Sebastiani P, Steinberg MH, Farber HW. Differential gene expression in pulmonary artery endothelial cells exposed to sickle cell plasma. Physiological Genomics. 21: 293-8. PMID 15741505 DOI: 10.1152/Physiolgenomics.00246.2004  0.105
2021 Farber HJ. The Most Important Learnings from the new Official American Thoracic Society (ATS) Clinical Practice Guidelines: Initiating Pharmacologic Treatment in Tobacco Dependent Adults. Archivos De Bronconeumologia. 57: 737-738. PMID 35698979 DOI: 10.1016/j.arbr.2021.04.018  0.102
2021 Farber HJ. The Most Important Learnings from the new Official American Thoracic Society (ATS) Clinical Practice Guidelines: Initiating Pharmacologic Treatment in Tobacco Dependent Adults. Archivos De Bronconeumologia. PMID 34030902 DOI: 10.1016/j.arbres.2021.04.010  0.102
2015 Farber HJ, Walley SC, Groner JA, Nelson KE. Clinical Practice Policy to Protect Children From Tobacco, Nicotine, and Tobacco Smoke. Pediatrics. 136: 1008-17. PMID 26504137 DOI: 10.1542/peds.2015-3108  0.102
2016 Farber HJ, Pakhale S, Neptune ER. Tobacco 21: An Important Public Policy to Protect Our Youth. Annals of the American Thoracic Society. PMID 27689306 DOI: 10.1513/AnnalsATS.201604-253AR  0.101
2010 Farber HJ. Introducing Pediatric Allergy, Immunology, and Pulmonology. Pediatric Allergy, Immunology, and Pulmonology. 23: 1. PMID 22332026 DOI: 10.1089/ped.2010.2301  0.099
2006 Menter A, Cather JC, Baker D, Farber HF, Lebwohl M, Darif M. The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis. Journal of the American Academy of Dermatology. 54: 61-3. PMID 16384756 DOI: 10.1016/j.jaad.2005.10.006  0.099
1998 Farber HJ. Risk of readmission to hospital for pediatric asthma. The Journal of Asthma : Official Journal of the Association For the Care of Asthma. 35: 95-9. PMID 9513588 DOI: 10.3109/02770909809055410  0.098
2017 Farber HJ. Imbalance in Level of Tobacco Smoke Exposure Between Groups Likely Explains the "Effect" of Palivizumab on Subsequent Wheezing. American Journal of Respiratory and Critical Care Medicine. PMID 29019703 DOI: 10.1164/rccm.201707-1527LE  0.096
2018 Krishnan S, Dozor AJ, Bacharier L, Lang JE, Irvin CG, Kaminsky D, Farber HJ, Gerald L, Brown M, Holbrook JT, Wise RA, Ryu J, Bose S, Razan Y, Saams J, et al. Clinical characterization of children with resistant airflow obstruction, a multicenter study. The Journal of Asthma : Official Journal of the Association For the Care of Asthma. 1-25. PMID 29771599 DOI: 10.1080/02770903.2018.1477956  0.095
2018 Zeiger AM, White MJ, Eng C, Oh SS, Witonsky J, Goddard PC, Contreras MG, Elhawary JR, Hu D, Mak ACY, Lee EY, Keys KL, Samedy LA, Risse-Adams O, Magaña J, ... ... Farber HJ, et al. Genetic Determinants of Telomere Length in African American Youth. Scientific Reports. 8: 13265. PMID 30185882 DOI: 10.1038/S41598-018-31238-3  0.094
2017 Farber HJ, Neptune ER, Ewart GW. Corrective Statements from the Tobacco Industry: More Evidence for Why We Need Effective Tobacco Control. Annals of the American Thoracic Society. PMID 29140104 DOI: 10.1513/AnnalsATS.201711-845GH  0.093
2021 Nair AA, Farber HJ, Chen H. Utilization of opioid vs. non-opioid analgesics in Medicaid and CHIP enrolled children with current asthma. Pharmacoepidemiology and Drug Safety. PMID 34322934 DOI: 10.1002/pds.5336  0.092
2017 Murrell DV, Lotze TE, Farber HJ, Crawford CA, Wiemann CM. The Experience of Families With Children With Spinal Muscular Atrophy Type I Across Health Care Systems. Journal of Child Neurology. 883073817716853. PMID 28671037 DOI: 10.1177/0883073817716853  0.092
2002 Zoeller RA, Grazia TJ, LaCamera P, Park J, Gaposchkin DP, Farber HW. Increasing plasmalogen levels protects human endothelial cells during hypoxia. American Journal of Physiology. Heart and Circulatory Physiology. 283: H671-9. PMID 12124215 DOI: 10.1152/Ajpheart.00524.2001  0.091
2018 Farber HJ, Neptune E, Ewart G. FDA Regulation of Tobacco Products: Time for a Course Correction. Annals of the American Thoracic Society. PMID 30407839 DOI: 10.1513/AnnalsATS.201809-597PS  0.091
2018 Leone FT, Carlsen KH, Chooljian D, Crotty Alexander LE, Detterbeck FC, Eakin MN, Evers-Casey S, Farber HJ, Folan P, Kathuria H, Latzka K, McDermott S, McGrath-Morrow S, Moazed F, Munzer A, et al. Recommendations for the Appropriate Structure, Communication, and Investigation of Tobacco Harm Reduction Claims. An Official American Thoracic Society Policy Statement. American Journal of Respiratory and Critical Care Medicine. 198: e90-e105. PMID 30320525 DOI: 10.1164/Rccm.201808-1443St  0.09
2020 Wang KY, Jadhav SP, Yenduri NJS, Lee SA, Farber HJ, Guillerman RP. E-cigarette or vaping product use-associated lung injury in the pediatric population: imaging features at presentation and short-term follow-up. Pediatric Radiology. PMID 32495177 DOI: 10.1007/s00247-020-04698-x  0.09
2015 Verla T, Marky A, Farber H, Petraglia FW, Gallis J, Lokhnygina Y, Parente B, Hickey P, Turner DA, Lad SP. Impact of advancing age on post-operative complications of deep brain stimulation surgery for essential tremor. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 22: 872-6. PMID 25669119 DOI: 10.1016/J.Jocn.2014.11.005  0.09
2015 Farber HJ, Nelson KE, Groner JA, Walley SC. Public Policy to Protect Children From Tobacco, Nicotine, and Tobacco Smoke. Pediatrics. 136: 998-1007. PMID 26504133 DOI: 10.1542/peds.2015-3109  0.09
2005 Wilson KC, Reardon C, Theodore AC, Farber HW. Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines: a case series and prospective, observational pilot study. Chest. 128: 1674-81. PMID 16162774 DOI: 10.1378/chest.128.3.1674  0.09
2020 Farber HJ. We Knew Tobacco Smoke Exposure Was Bad …. Chest. 158: 854-855. PMID 32892880 DOI: 10.1016/j.chest.2020.04.008  0.087
2014 Farber HJ. Harm of in utero tobacco smoke exposure: a heritable trait? Chest. 145: 1182-4. PMID 24889426 DOI: 10.1378/chest.13-2868  0.085
2014 Burley U, Hsu J, Alva D, Nguyen E, Roth L, Galanter J, Oh S, Eng C, Lurmann F, Kumar R, Farber HJ, Serebrisky D, Borrell L, Sen S, Rodriguez-Cintron W, et al. Unrecognized Allergic Rhinoconjunctivitis and Allergic Sensitization Among Latino Youth (GALA II Study) Journal of Allergy and Clinical Immunology. 133: AB74. DOI: 10.1016/J.Jaci.2013.12.287  0.081
2017 Folan P, Spatarella A, Jacobsen D, Farber HJ. Why Do I Smoke and Why Do I Keep Smoking? American Journal of Respiratory and Critical Care Medicine. 196: P7-P8. PMID 28809510 DOI: 10.1164/rccm.1964P7  0.078
2015 Farber HJ. The Harm of Tobacco Starts Before Birth. Chest. 148: 573-4. PMID 26324129 DOI: 10.1378/chest.15-0767  0.074
2010 Farber HJ, Abramson SL. Celebrating our first year as pediatric allergy, immunology, and pulmonology Pediatric, Allergy, Immunology, and Pulmonology. 23: 215-216. DOI: 10.1089/ped.2010.2308  0.072
2002 Graven KK, Molvar C, Roncarati JS, Klahn BD, Lowrey S, Farber HW. Identification of protein disulfide isomerase as an endothelial hypoxic stress protein American Journal of Physiology - Lung Cellular and Molecular Physiology. 282: L996-L1003. PMID 11943664  0.072
2008 Wilson KC, Farber HW. Propylene glycol accumulation during continuous-infusion lorazepam in critically ill patients. Journal of Intensive Care Medicine. 23: 413; author reply 41. PMID 19019841 DOI: 10.1177/0885066608324175  0.07
2017 Galanter JM, Gignoux CR, Oh SS, Torgerson D, Pino-Yanes M, Thakur N, Eng C, Hu D, Huntsman S, Farber HJ, Avila PC, Brigino-Buenaventura E, LeNoir MA, Meade K, Serebrisky D, et al. Differential methylation between ethnic sub-groups reflects the effect of genetic ancestry and environmental exposures. Elife. 6. PMID 28044981 DOI: 10.7554/Elife.20532  0.07
2016 Farber HJ, Buckwold FJ, Lachman B, Simpson JS, Buck E, Arun M, Valadez AM, Ruiz T, Alonzo J, Henry A, Cos-Okpalla N, Nguyen K, Brendel W, Small J, Glomb WB. Observed Effectiveness of Palivizumab for 29-36-Week Gestation Infants. Pediatrics. PMID 27432850 DOI: 10.1542/peds.2016-0627  0.07
2015 Pino-Yanes M, Gignoux CR, Galanter JM, Levin AM, Campbell CD, Eng C, Huntsman S, Nishimura KK, Gourraud PA, Mohajeri K, O'Roak BJ, Hu D, Mathias RA, Nguyen EA, Roth LA, ... ... Farber HJ, et al. Genome-wide association study and admixture mapping reveal new loci associated with total IgE levels in Latinos. The Journal of Allergy and Clinical Immunology. 135: 1502-10. PMID 25488688 DOI: 10.1016/J.Jaci.2014.10.033  0.069
2014 Farber H. Millions for credit: Peace with Algiers and the establishment of America's commercial reputation overseas, 1795-96 Journal of the Early Republic. 34: 187-217. DOI: 10.1353/Jer.2014.0028  0.069
2020 Farber HJ, Conrado Pacheco G M, Galiatsatos P, Folan P, Lamphere T, Pakhale S. Harms of Electronic Cigarettes: What the Health Care Provider Needs to Know. Annals of the American Thoracic Society. PMID 33284731 DOI: 10.1513/AnnalsATS.202009-1113CME  0.068
2003 Ortonne JP, Lebwohl M, Em Griffiths C, Barber K, Murray E, Bourcier M, Gulliver W, Langley R, Guenther L, Papp K, Tan J, Poulin Y, Heenen M, Lambert J, De La Brassine M, ... ... Farber H, et al. Alefacept-induced decreases in circulating blood lymphocyte counts correlate with clinical response in patients with chronic plaque psoriasis European Journal of Dermatology. 13: 117-123. PMID 12695125  0.068
2017 Farber HJ. Impact of the 2014 American Academy of Pediatrics guidance on respiratory syncytial virus and bronchiolitis hospitalization rates for infants born prematurely. The Journal of Pediatrics. PMID 28237377 DOI: 10.1016/j.jpeds.2017.01.054  0.066
2007 Jernbro S, Rocha PS, Keiter S, Skutlarek D, Färber H, Jones PD, Giesy JP, Hollert H, Engwall M. Perfluorooctane sulfonate increases the genotoxicity of cyclophosphamide in the micronucleus assay with V79 cells. Further proof of alterations in cell membrane properties caused by PFOS. Environmental Science and Pollution Research International. 14: 85-7. PMID 17455816 DOI: 10.1065/Espr2007.01.384  0.066
2018 Spatarella A, Folan P, Farber HJ. Cigars. American Journal of Respiratory and Critical Care Medicine. 197: P7-P8. PMID 29493316 DOI: 10.1164/rccm.1975P7  0.062
2001 Klings ES, Farber HW. Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease Respiratory Research. 2: 280-285. PMID 11686897 DOI: 10.1186/rr70  0.06
2024 Pacheco Gallego MC, Farber HJ. The Evidence of Electronic Cigarettes for Harm Reduction Is Not There. American Journal of Respiratory and Critical Care Medicine. PMID 38271700 DOI: 10.1164/rccm.202310-1804LE  0.06
2017 Farber HJ, Folan P. The Tobacco Industry Targets Youth. American Journal of Respiratory and Critical Care Medicine. 196: P11-P12. PMID 28914573 DOI: 10.1164/rccm.1966P11  0.058
1991 Farber HJ, Berg RA. Bacterial tracheitis as a complication of endotracheal intubation. Pediatric Pulmonology. 11: 87-9. PMID 1923672 DOI: 10.1002/PPUL.1950110113  0.058
2002 Forgione MA, Weiss N, Heydrick S, Cap A, Klings ES, Bierl C, Eberhardt RT, Farber HW, Loscalzo J. Cellular glutathione peroxidase deficiency and endothelial dysfunction American Journal of Physiology - Heart and Circulatory Physiology. 282: H1255-H1261. PMID 11893559 DOI: 10.1152/Ajpheart.00598.2001  0.057
2017 Farber HJ. Author's Response: On Careful Reanalysis of Our Findings I Stand by Our Results and Interpretation. Pediatrics. 139. PMID 28039214 DOI: 10.1542/peds.2016-3483B  0.054
2002 Jones H, Aguila E, Farber HW. Gabapentin toxicity requiring intubation in a patient receiving long-term hemodialysis [5] Annals of Internal Medicine. 137: 74-75. PMID 12093261  0.052
2016 Farber HJ, Neptune E, Pakhale S. Tobacco 21-An Important Public Policy to Protect our Youth. American Journal of Respiratory and Critical Care Medicine. 194: P19-P20. PMID 27905848 DOI: 10.1164/rccm.19411P19  0.051
2017 Hernandez-Pacheco N, Flores C, Alonso S, Eng C, Mak AC, Hunstman S, Hu D, White MJ, Oh SS, Meade K, Farber HJ, Avila PC, Serebrisky D, Thyne SM, Brigino-Buenaventura E, et al. Identification of a novel locus associated with skin colour in African-admixed populations. Scientific Reports. 7: 44548. PMID 28300201 DOI: 10.1038/Srep44548  0.05
2002 Frank RD, Farber H, Lanzmich R, Floege J, Kierdorf HP. In vitro studies on hirudin elimination by haemofiltration: Comparison of three high-flux membranes Nephrology Dialysis Transplantation. 17: 1957-1963. PMID 12401853  0.048
2008 Farber HS. Is the company man an anachronism? Trends in long-term employment in the united states, 1973 to 2006 The Price of Independence: the Economics of Early Adulthood. 56-83.  0.048
2001 Farber HS, Western B. Accounting for the decline of unions in the private sector, 1973-1998 Journal of Labor Research. 22: 484-485. DOI: 10.1007/S12122-001-1017-8  0.047
2015 Farber HS, Rothstein J, Valletta RG. The effect of extended unemployment insurance benefits: Evidence from the 2012-2013 phase out American Economic Review. 105: 171-176. DOI: 10.1257/Aer.P20151088  0.047
2020 Farber HJ. New Understanding of the Health Hazards of Electronic Cigarettes and Vaping. Pediatrics in Review. 41: 152-154. PMID 32123028 DOI: 10.1542/pir.2019-0269  0.044
2012 Garzon-Muvdi T, Schiapparelli P, ap Rhys C, Guerrero-Cazares H, Smith C, Kim DH, Kone L, Farber H, Lee DY, An SS, Levchenko A, Quiñones-Hinojosa A. Regulation of brain tumor dispersal by NKCC1 through a novel role in focal adhesion regulation. Plos Biology. 10: e1001320. PMID 22570591 DOI: 10.1371/Journal.Pbio.1001320  0.044
2007 Bishop DM, Farber HB. Joining the legal significance of adolescent developmental capacities with the legal rights provided by In re Gault Rutgers Law Review. 60: 125-173.  0.044
2008 Farber HJ. What color is your yellow zone? Is there a role for escalation of anti-inflammatory therapy short of an oral corticosteroid burst? Pediatric Asthma, Allergy and Immunology. 21: 24-30. DOI: 10.1089/pai.2007.0020  0.043
2013 Farber HJ. Highlights from this issue Pediatric, Allergy, Immunology, and Pulmonology. 26: 55-56. PMID 24636600 DOI: 10.1089/ped.2013.2621  0.043
2005 Adewoye AH, Klings ES, Farber HW, Palaima E, Bausero MA, McMahon L, Odhiambo A, Surinder S, Yoder M, Steinberg MH, Asea A. Sickle cell vaso-occlusive crisis induces the release of circulating serum heat shock protein-70. American Journal of Hematology. 78: 240-2. PMID 15726596 DOI: 10.1002/Ajh.20292  0.042
2010 Walkey AJ, Ieong M, Alikhan M, Farber HW. Cardiopulmonary exercise testing with right-heart catheterization in patients with systemic sclerosis. The Journal of Rheumatology. 37: 1871-7. PMID 20551099 DOI: 10.3899/jrheum.091424  0.041
2015 Verla T, Adogwa O, Elsamadicy A, Moreno JR, Farber H, Cheng J, Bagley CA. Effects of Psoas Muscle Thickness on Outcomes of Lumbar Fusion Surgery. World Neurosurgery. PMID 26619920 DOI: 10.1016/J.Wneu.2015.11.022  0.04
2023 Nair AA, Placencia JL, Farber HJ, Aparasu RR, Johnson M, Chen H. Trends in repeat opioid analgesic prescription utilization for acute pain in children: 2013-2018. Academic Pediatrics. PMID 37802247 DOI: 10.1016/j.acap.2023.09.020  0.04
2022 Nair AA, Placencia JL, Farber HJ, Aparasu RR, Johnson M, Chen H. Association between initial opioid prescription duration and 30-day risk of receiving repeat opioid among children. Academic Pediatrics. PMID 35863737 DOI: 10.1016/j.acap.2022.06.006  0.039
2005 Card D, Farber HS. Introduction: Essays in honor of Orley Ashenfelter Industrial and Labor Relations Review. 58: 331-334.  0.038
2015 Verla T, Adogwa O, Toche U, Farber H, Petraglia F, Murphy KR, Thomas S, Fatemi P, Gottfried O, Bagley CA, Lad SP. Impact of Increasing Age on Outcomes of Spinal Fusion in Adult Scoliosis. World Neurosurgery. PMID 26546999 DOI: 10.1016/J.Wneu.2015.10.061  0.037
2015 Farber HS, Valletta RG. Do extended unemployment benefits lengthen unemployment spells? Evidence from recent cycles in the U.S. Labor market Journal of Human Resources. 50: 873-909. DOI: 10.3368/jhr.50.4.873  0.036
2012 Keiter S, Baumann L, Färber H, Holbech H, Skutlarek D, Engwall M, Braunbeck T. Long-term effects of a binary mixture of perfluorooctane sulfonate (PFOS) and bisphenol A (BPA) in zebrafish (Danio rerio). Aquatic Toxicology (Amsterdam, Netherlands). 118: 116-29. PMID 22542737 DOI: 10.1016/j.aquatox.2012.04.003  0.036
2009 Farber H. The rise and fall of the province of Lygonia, 1643-1658 New England Quarterly-a Historical Review of New England Life and Letters. 82: 490-513. DOI: 10.1162/Tneq.2009.82.3.490  0.036
2013 Eisenberg T, Farber HS. Why do plaintiffs lose appeals? Biased trial courts, litigious losers, or low trialwin rates? American Law and Economics Review. 15: 73-109. DOI: 10.1093/Aler/Ahs021  0.034
2017 Farber HJ. Author's Response: One Should Not Dismiss Our Findings as "Just Statistics". Pediatrics. 139. PMID 28246348 DOI: 10.1542/peds.2016-4247B  0.034
2008 Kistemann T, Hundhausen J, Herbst S, Classen T, Färber H. Assessment of a groundwater contamination with vinyl chloride (VC) and precursor volatile organic compounds (VOC) by use of a geographical information system (GIS). International Journal of Hygiene and Environmental Health. 211: 308-17. PMID 17869578 DOI: 10.1016/j.ijheh.2007.02.011  0.033
2002 Farber HS, Western B. Ronald Reagan and the politics of declining union organization British Journal of Industrial Relations. 40: 385-401. DOI: 10.1111/1467-8543.00240  0.033
2012 Farber HJ. Promoting tobacco to women of reproductive age harms fetuses. Chest. 141: 839-40. PMID 22474143 DOI: 10.1378/chest.11-2334  0.031
2010 Ashenfelter OC, Farber H, Ransom MR. Labor market monopsony Quarterly Review of Biology. 85: 203-210. DOI: 10.1086/653654  0.03
2010 Ashenfelter OC, Farber H, Ransom MR. Labor market monopsony Quarterly Review of Biology. 85: 203-210.  0.03
2012 Farber HS. Unemployment in the Great Recession: Did the housing market crisis prevent the unemployed from moving to take jobs American Economic Review. 102: 520-525. DOI: 10.1257/aer.102.3.520  0.026
2006 Fiack CA, Farber HW. Heart failure with preserved ejection fraction. The New England Journal of Medicine. 355: 1828; author reply 1. PMID 17065647 DOI: 10.1056/NEJMc062229  0.025
2004 Piacquadio DJ, Chen DM, Farber HF, Fowler JF, Glazer SD, Goodman JJ, Hruza LL, Jeffes EW, Ling MR, Phillips TJ, Rallis TM, Scher RK, Taylor CR, Weinstein GD. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. Archives of Dermatology. 140: 41-6. PMID 14732659 DOI: 10.1001/archderm.140.1.41  0.025
2002 Farber HJ. On the abuse of acronyms. American Journal of Respiratory and Critical Care Medicine. 166: 1607-8. PMID 12471077 DOI: 10.1164/ajrccm.166.12.251b  0.024
2008 Farber HJ. In my opinion - Interview with an expert Pediatric Asthma, Allergy and Immunology. 21: 1-5. DOI: 10.1089/pai.2007.4987  0.023
2015 Lendowski L, Färber H, Holy A, Darius A, Ehrich B, Wippermann C, Küfner B, Exner M. Accidental contamination of a German town's drinking water with sodium hydroxide. International Journal of Hygiene and Environmental Health. 218: 366-9. PMID 25687345 DOI: 10.1016/j.ijheh.2015.01.006  0.022
2016 Farber HJ. Rebuttal From Dr Farber. Chest. PMID 27426478 DOI: 10.1016/j.chest.2016.06.027  0.022
2003 Wilson KC, Bielska B, Farber HW. Mycobacterium marinum osteomyelitis Orthopedics. 26: 331-332. PMID 12650330  0.02
2004 Farber HB. The role of the parent/guardian in juvenile custodial interrogations: Friend or foe? American Criminal Law Review. 41: 1277-1312.  0.019
2015 Farber H. Union organizing decisions in a deteriorating environment: The composition of representation elections and the decline in turnout Industrial and Labor Relations Review. 68: 1126-1156. DOI: 10.1177/0019793915592623  0.019
2015 Ramdass P, Mullick S, Farber HF. Viral Skin Diseases. Primary Care. 42: 517-67. PMID 26612372 DOI: 10.1016/j.pop.2015.08.006  0.017
2013 Farber HJ. Public policy, air quality, and protecting the most vulnerable. Chest. 144: 1093-4. PMID 24081337 DOI: 10.1378/chest.13-0772  0.016
2005 Farber HS. Nonunion wage rates and the threat of unionization Industrial and Labor Relations Review. 58: 335-352.  0.016
2008 Farber HS. Reference-dependent preferences and labor supply: The case of New York City taxi drivers American Economic Review. 98: 1069-1082. DOI: 10.1257/aer.98.3.1069  0.014
2006 Zheng H, Duclos RI, Smith CC, Farber HW, Zoeller RA. Synthesis and biological properties of the fluorescent ether lipid precursor 1-O-[9'-(1''-pyrenyl)]nonyl-sn-glycerol. Journal of Lipid Research. 47: 633-42. PMID 16369049 DOI: 10.1194/Jlr.M500493-Jlr200  0.014
2015 Farber HS. Why you can't find a taxi in the rain and other labor supply lessons from cab drivers Quarterly Journal of Economics. 130: 1975-2026. DOI: 10.1093/qje/qjv026  0.012
2016 Farber HJ. Response. Chest. 149: 1106-7. PMID 27055702 DOI: 10.1016/j.chest.2016.01.017  0.011
2012 Farber HS. The cost of job loss in the great recession: How bad has it been? Economists' Voice. 9. DOI: 10.1515/1553-3832.1886  0.01
2009 Farber HS, Hallock KF. The changing relationship between job loss announcements and stock prices: 1970-1999 Labour Economics. 16: 1-11. DOI: 10.1016/j.labeco.2008.04.002  0.01
2008 Gaposchkin DP, Farber HW, Zoeller RA. On the importance of plasmalogen status in stimulated arachidonic acid release in the macrophage cell line RAW 264.7. Biochimica Et Biophysica Acta. 1781: 213-9. PMID 18328831 DOI: 10.1016/J.Bbalip.2008.01.007  0.01
2006 Skutlarek D, Exner M, Färber H. Perfluorinated surfactants in surface and drinking waters. Environmental Science and Pollution Research International. 13: 299-307. PMID 17067024  0.01
2005 Hollert H, Dürr M, Holtey-Weber R, Islinger M, Brack W, Färber H, Erdinger L, Braunbeck T. Endocrine disruption of water and sediment extracts in a non-radioactive dot blot/RNAse protection-assay using isolated hepatocytes of rainbow trout. Environmental Science and Pollution Research International. 12: 347-60. PMID 16305141  0.01
2005 Farber HS. Is tomorrow another day? The labor supply of New York City cabdrivers Journal of Political Economy. 113: 46-82. DOI: 10.1086/426040  0.01
2004 Farber HS. JOB LOSS IN THE UNITED STATES, 1981-2001 Research in Labor Economics. 23: 69-117. DOI: 10.1016/S0147-9121(04)23003-5  0.01
Hide low-probability matches.